The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, C.
Right arrow Articles by Goldschneider, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, C.
Right arrow Articles by Goldschneider, I.
The Journal of Immunology, 2000, 164: 1961-1970.
Copyright © 2000 by The American Association of Immunologists

Murine Pro-B Cells Require IL-7 and Its Receptor Complex to Up-Regulate IL-7R{alpha}, Terminal Deoxynucleotidyltransferase, and cµ Expression1

Chiju Wei, Richard Zeff and Irving Goldschneider2

Department of Pathology, University of Connecticut Health Center, Farmington, CT 06030

Phenotypic analysis of bone marrow cells from IL-7 knockout (KO) mice revealed that B cell development is blocked precisely at the transition between pro-B cells and pre-B cells. In contrast, the generation of pre-pro-B cells and pro-B cells appeared to be normal, as judged by total cell numbers, proliferative indexes, D-JH and V-DJH gene rearrangements, and mRNA for recombinase-activating gene-1 (RAG-1), RAG-2, TdT, Igµ, {lambda}5, and VpreB. However, upon closer inspection, several abnormalities in pro-B cell development were identified that could be corrected by injection of rIL-7 in vivo. These included the absence of the subset of late pro-B cells that initiates cµ expression for pre-B cell Ag receptor (BCR) formation, and the failure of pro-B cells to up-regulate TdT and the IL-7R{alpha} (but not the common {gamma}-chain) chain. Similar defects were present in common {gamma}-chain and Jak3 KO mice, but not in {lambda}5 or (excluding cytoplasmic Ig µ heavy chain (cµ)) RAG-1 KO mice, all of which also arrest at the late pro-B cell stage. Consequently, up-regulation of TdT and IL-7R{alpha} expression requires signaling through the high affinity IL-7R, but does not require cµ expression or a functional pre-BCR. Taken together, these results suggest that IL-7 and its receptor complex are essential for 1) up-regulating the expression of TdT and IL-7R{alpha}, 2) initiating the production of cµ, and 3) promoting the formation of a functional pre-BCR in/on pro-B cells. These key events, in turn, appear to be prerequisite both for differentiation of pro-B cells to pre-B cells and for proliferation of these cell subsets upon continued stimulation with IL-7.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
V. I. Brown, J. Hulitt, J. Fish, C. Sheen, M. Bruno, Q. Xu, M. Carroll, J. Fang, D. Teachey, and S. A. Grupp
Thymic Stromal-Derived Lymphopoietin Induces Proliferation of Pre-B Leukemia and Antagonizes mTOR Inhibitors, Suggesting a Role for Interleukin-7R{alpha} Signaling
Cancer Res., October 15, 2007; 67(20): 9963 - 9970.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
J. Feng, H. Wang, and H. C. Morse III
Functional Deficiency in IL-7 Caused by an N-Ethyl-N-nitrosourea-Induced Point Mutation
Genetics, February 1, 2007; 175(2): 545 - 551.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
R. Wen, Y. Chen, L. Bai, G. Fu, J. Schuman, X. Dai, H. Zeng, C. Yang, R. P. Stephan, J. L. Cleveland, et al.
Essential Role of Phospholipase C{gamma}2 in Early B-Cell Development and Myc-Mediated Lymphomagenesis
Mol. Cell. Biol., December 15, 2006; 26(24): 9364 - 9376.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Fujimura, Y. Xing, M. Takeya, Y. Yamashita, K. Ohshima, K. Kuwahara, and N. Sakaguchi
Increased Expression of Germinal Center-Associated Nuclear Protein RNA-Primase Is Associated with Lymphomagenesis
Cancer Res., July 1, 2005; 65(13): 5925 - 5934.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Sakaguchi, T. Kimura, S. Matsushita, S. Fujimura, J. Shibata, M. Araki, T. Sakamoto, C. Minoda, and K. Kuwahara
Generation of High-Affinity Antibody against T Cell-Dependent Antigen in the Ganp Gene-Transgenic Mouse
J. Immunol., April 15, 2005; 174(8): 4485 - 4494.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
P. M. Oliver, M. Wang, Y. Zhu, J. White, J. Kappler, and P. Marrack
Loss of Bim Allows Precursor B Cell Survival But Not Precursor B Cell Differentiation in the Absence of Interleukin 7
J. Exp. Med., November 1, 2004; 200(9): 1179 - 1187.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. I. Brown, J. Fang, K. Alcorn, R. Barr, J. M. Kim, R. Wasserman, and S. A. Grupp
Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling
PNAS, December 9, 2003; 100(25): 15113 - 15118.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. C. Otero and R. C. Rickert
CD19 Function in Early and Late B Cell Development. II. CD19 Facilitates the Pro-B/Pre-B Transition
J. Immunol., December 1, 2003; 171(11): 5921 - 5930.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S.-K. Lee, J. F. Kalinowski, S. L. Jastrzebski, L. Puddington, and J. A. Lorenzo
Interleukin-7 Is a Direct Inhibitor of in Vitro Osteoclastogenesis
Endocrinology, August 1, 2003; 144(8): 3524 - 3531.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S. R. Dillon and M. S. Schlissel
Partial restoration of B cell development in Jak-3-/- mice achieved by co-expression of IgH and E{micro}-myc transgenes
Int. Immunol., August 1, 2002; 14(8): 893 - 904.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Tsuruyama, T. Nakamura, G. Jin, M. Ozeki, Y. Yamada, and H. Hiai
Constitutive activation of Stat5a by retrovirus integration in early pre-B lymphomas of SL/Kh strain mice
PNAS, June 11, 2002; 99(12): 8253 - 8258.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. J. Fry and C. L. Mackall
Interleukin-7: from bench to clinic
Blood, May 13, 2002; 99(11): 3892 - 3904.
[Full Text] [PDF]

Home page
 JEMHome page
T. L. Carvalho, T. Mota-Santos, A. Cumano, J. Demengeot, and P. Vieira
Arrested B Lymphopoiesis and Persistence of Activated B Cells in Adult Interleukin 7-/- Mice
J. Exp. Med., October 15, 2001; 194(8): 1141 - 1150.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Lai and I. Goldschneider
Cutting Edge: Identification of a Hybrid Cytokine Consisting of IL-7 and the {beta}-Chain of the Hepatocyte Growth Factor/Scatter Factor
J. Immunol., October 1, 2001; 167(7): 3550 - 3554.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. A. Martinez-M., S. Minguet, P. Gonzalo, P. G. Soro, B. de Andres, A. Izcue, M. A. R. Marcos, and M.-L. Gaspar
Long-lived polyclonal B-cell lines derived from midgestation mouse embryo lymphohematopoietic progenitors reconstitute adult immunodeficient mice
Blood, September 15, 2001; 98(6): 1862 - 1871.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Kouro, K. L. Medina, K. Oritani, and P. W. Kincade
Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators
Blood, May 1, 2001; 97(9): 2708 - 2715.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.